Paricalcitol in hemodialysis patients with secondary hyperparathyroidism and its potential benefits

doi:10.12998/wjcc.v9.i33.10172

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 33

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2560)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

184

WORD

104

HTML

1417

Figures (1-1)

196

Tables (1-3)

158

Sum=2059

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

204

Download

297

Sum=501

Nov 26, 2021 (publication date) through Apr 23, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Clin Cases. Nov 26, 2021; 9(33): 10172-10179
Published online Nov 26, 2021. doi: 10.12998/wjcc.v9.i33.10172

Open in New Tab Full Size Figure Download Figure

Figure 1 Changes in the biochemical index level over time. ^aP < 0.05, ^bP < 0.01 vs baseline. A: Intact parathyroid hormone level; B: Alkaline phosphatase level; C: Serum calcium and phosphate levels; D: Serum calcium × phosphate product. iPTH: Intact parathyroid hormone; ALP: Alkaline phosphatase; Ca: Calcium; P: Phosphate.

Citation: Chen X, Zhao F, Pan WJ, Di JM, Xie WN, Yuan L, Liu Z. Paricalcitol in hemodialysis patients with secondary hyperparathyroidism and its potential benefits. World J Clin Cases 2021; 9(33): 10172-10179
URL: https://www.wjgnet.com/2307-8960/full/v9/i33/10172.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i33.10172